Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on August 5, 2025
Core Documents, Inc. Announces Affordable ICHRA Plan Solutions with Special Enrollment Period Benefits for Employees
A key advantage of setting up an ICHRA is the ability to trigger a Special Enrollment Period (SEP) for employees, to purchase individual health coverage. BRADENTON, FL, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- Core Documents, Inc., the nation …
Christie Medical Holdings, Inc is Now a Vizient Contracted Supplier, Expanding Access to VeinViewer® Technology
Christie VeinViewer® vascular imaging is accepted as a Vizient® contracted supplier, nation's largest provider-driven healthcare performance improvement company FL, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- Christie Medical Holdings, Inc ( …
CHOICE HRA Provisions Removed from One Big Beautiful Bill Act in Final Senate Revisions
The removal of the CHOICE HRA provisions from the OBBBA means the ICHRA framework remains unchanged under the existing 2019 regulations. BRADENTON, FL, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- Core Documents, a leading provider of IRS Section …
BeneLynk Continues to Grow as Market Leader with Promotion and Addition to Executive Team: Michel Martinez Joins as CTO
SUNRISE, FL, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- BeneLynk, the nation’s leading provider of social care solutions for managed care companies, is proud to announce two changes to the BeneLynk executive team. On July 28th, Michel Martinez …
Nxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management
Pipeline led by a new proprietary oral small molecule GLP-1 agonist and six additional innovative programs targeting the GIP, Amylin and Apelin receptors, aiming to transform treatment landscape Designed to address emerging areas of patient need, including …
Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform
HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second U.S. Food …
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role …
Interior Designer Launches Fine Art Photography Venture for Commercial and Residential Spaces
CLEARWATER, FL, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- After more than 35 years in interior design, Dina Marie is taking a new approach to transforming spaces—this time through the lens of her camera. The Florida-based designer has launched …
Peer-Reviewed Study Confirms Within Health's Remote PHP/IOP Model Delivers Consistent Results Across Ages
Study confirms strong outcomes across all ages, validating Within Health’s intentionally-designed, fully remote model as a proven alternative to in‑person care. COCONUT GROVE, FL, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- Within Health, a …
BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
MELVILLE, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced …
Galecto Reports Second Quarter 2025 Operating and Financial Results
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …
Fractyl Health Announces Proposed Public Offering
BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company pioneering pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (“T2D”), …
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
JUPITER, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional …
Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update
- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC phase 2 trial demonstrates 63% response rate observed among 43 evaluable patients and 79% overall survival rate at 12-months - Based on the Company’s current operating plan, existing …
Supernus Announces Second Quarter 2025 Financial Results
Net sales of Qelbree® increased 31% in the second quarter of 2025, compared to the same period in 2024. Net sales of Qelbree of $77.6 million and $142.3 million in the second quarter and first six months of 2025, respectively. Net sales of GOCOVRI® …
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025
CAMBRIDGE, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …